Altered cardiovascular responses to nitrosorbide in alcohol withdrawal

Neuropsychobiology

Volumn 48, Issue 3, 2003, Pages 124-130

  Kähkönen, Seppo ^a,b   Zvartau, Edwin E ^c  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c PAVLOV FIRST SAINT PETERSBURG STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Alcohol withdrawal; Blood pressure; Heart rate; Isosorbide dinitrate; Nitric oxide; Pharmacokinetics; Stroke volume

Indexed keywords

ISOSORBIDE DINITRATE; NITRIC OXIDE;

ADULT; ALCOHOL WITHDRAWAL; AREA UNDER THE CURVE; ARTICLE; CARDIOVASCULAR RESPONSE; CARDIOVASCULAR SYSTEM; CLINICAL ARTICLE; CLINICAL OBSERVATION; COMPARATIVE STUDY; CONTROLLED STUDY; HEART; HEART STROKE VOLUME; HUMAN; HYPOTENSION; MALE; PRIORITY JOURNAL; TACHYCARDIA;

ADULT; AREA UNDER CURVE; BLOOD PRESSURE; CARDIAC OUTPUT; ETHANOL; HUMANS; ISOSORBIDE DINITRATE; MALE; SUBSTANCE WITHDRAWAL SYNDROME; VASODILATOR AGENTS;

EID: 0242299670     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000073628     Document Type: Article

References (42)

1. Gross MM, Lewis E, Hastey J: Acute alcohol withdrawal syndrome; in Clinical Pathology. New York, Plenum Press, 1974, vol 3: Biology of Alcoholism, pp 191-263.
2. Koch-Weser J, Sellers EM, Kalant H: Alcohol intoxication and withdrawal. N Engl J Med 1976;294:757-762.
3. Carlsson C: Haemodynamic studies in alcoholics in the withdrawal phase. Int J Clin Pharmacol Ther Toxicol 1971;3:61-63.
4. Beckman H, Frank RR, Robertson RD, Brady KA, Coin EJ: Evaluation of blood pressure during early alcohol withdrawal. Ann Emerg Med 1981;10:32-35.
5. Saunders JB, Bevers BC, Paton A: Alcohol-induced hypertension. Lancet 1981;ii:653-656.
6. Clark LT, Friedman HS: Hypertension associated with alcohol withdrawal: Assessment of mechanisms and complications. Alcoholism: Clin Exper Res 1985;9:125-130.
7. Kähkönen S, Bondarenko BB: Cardiovascular changes in alcohol patients during withdrawal phase. German J Psychiatry 2000;3:1-6.
8. Potter JF, Bannan LT, Beevers DG: Alcohol and hypertension. Br J Addiction 1984;79:365-373.
9. Kähkönen S: Alcohol withdrawal changes cardiovascular responses to propranolol challenge. Neuropsychobiology, in press.
10. Smals AG, Kloppenberg PW, Njo T, Knoben JN, Ruland CM: Alcohol-induced cushingoid syndrome. Br Med J 1976;ii:1298-1299.
11. Bannan LT, Potter JP, Beevers DG, Saunders JB, Walterns JRF, Ingram MC: Effect of alcohol withdrawal on blood pressure, plasma renin activity, aldosterone, cortisol and dopamine-hydrozulace. Clin Sci 1984;66:659-663.
12. Potter JF, Bannan LT, Beevers DG: The effect of a non-selective lipophilic beta-blocker on the blood pressure and noradrenaline, vasopressin, corticol and renin release during alcohol withdrawal. Clin Exp Hypertens 1984;6:1147-1160.
13. Jenkins JS, Connolly J: Adrenocortical response to ethanol in man. Br Med J 1968; ii:804-805.
14. Arkwright PD, Beilin LJ, Rouse L, Vandongen R: The pressor effect of moderate alcohol consumption in man: A search for mechanism. Circulation 1982;66:515-519.
15. De Marchi S, Cecchin E: Alcohol withdrawal and hypertension: Evidence for a kidney abnormality. Clin Sci 1985;69:239-240.
16. McCall T, Vallance P: Nitric oxide take centre-stage with newly defined roles. Trends Pharmacol Sci 1992;13:1-6.
17. Moncada S, Palmer RMJ, Higgs EA: Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109-141.
18. Adams ML, Cicero TJ: Alcohol intoxication and withdrawal: The role of nitric oxide. Alcohol 1998;16:153-158.
19. Dollery C: Therapeutic drugs. Edinburg, Chur-chill Livingstone, 1991, vol 1, pp I104-I110, vol 2, pp P272-P278, pp V12-V19.
20. Dollery C: Therapeutic drugs. Edinburg, Chur-chill Livingstone, 1991, vol 1, pp I104-I110, vol 2, pp P272-P278, pp V12-V19.
21. Lane EA, Guthrie S, Linnoila M: Effects of ethanol on drugs and metabolite pharmacokinetics. Clin Pharmacokin 1985;10:228-247.
22. Mattila MJ: Alcohol and drug interactions. Ann Med 1990;22:363-369.
23. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 3, rev. Washington, American Psychiatric Association, 1987, pp 129-130.
24. Kubicek WG, Karnegis JN, Patterson RP, Witsoe DA, Mattson RH: Development and evaluation of an impedance cardiac output system. Aerospace Med 1966;37:1208-1212.
25. Pushkar YT, Bolshov VM, Yelisarova NA: Determination of the cardiac output by impedance cardiography (in Russian). Cardiology 1977;17:85-90.
26. Gundarov IA, Pushkar YT, Konstantinov YI: The central cardiovascular norms determined by impedance cardiography (in Russian). Ther Arch 1983;55:26-28.
27. Sherwood A, Allen MT, Fahrenberg J, Kelsey RM, Lovallo WR, van Doornen LJP: Methodological guidelines for impedance cardiography. Psychophysiology 1990;27:1-23.
28. Fuller HG: The validy of cardiac output measurement by thoracic impedance: A meta-analysis. Clin Invest Med 1992;15:103-112.
29. Kokkonen P: Determination of isosorbide dinitrate, isosorbide-2- mononitrate and isosorbide-5-mononitrate in human plasma by capillary gas chromotography. Internal report, Orion Corporation Ltd., 1987.
30. Bennett BM, Marks GS: How does nitroglycerin induce vascular smooth muscle relaxation? Trends Pharmacol Sci 1984;5:329-332.
31. Brien JF, McLaughlin BE, Kobus SM, et al: Mechanism of glyceryl trinitrate-induced vasodilation. 1. Relationship between drug biotransformation, tissue cyclic GMP elevation and relaxation of rabbit aorta. J Pharmacol Exp Ther 1987;745:310-321.
32. Gruetter CA, Gruetter DY, Lyon JE, Kadowitz PJ, Ignarro LJ: Relationship between cyclic guanosine 3′:5′-monophosphate formation and relaxation of coronary arterial smooth muscle by glyceryl trinitrate, nitroprusside, nitrite and nitric oxide: effects of methylene blue and methemoglobin. J Pharmacol Exp Ther 1981;219:181-219.
33. Adams ML, Sewing BN, Chen J, Meyer ER, Cicero TJ: Nitric oxide-related agents alter alcohol withdrawal in male rats. Alcohol Clin Exp Res 1995;19:195-199.
34. Kaverina NV, Vysotskaya NB, Rosonov YuB, Shugina TM: Connection between central action of glyceryl trinitrate and monoamine metabolism of the brain. Bull Exp Biol Med 1967;64:1310-1313.
35. Ma S, Long PL: Central noradrenergic activity and the cardiovascular effects of nitroglycerin and amyl nitrate. J Cardiovas Pharmacol 1992;20:826-836.
36. Nutt DJ, Glue P, Molyneux S, Clark EC: Alfa-2-adrenoceptor function in alcohol withdrawal. Alcohol Clin Exp Res 1988;12:14-18.
37. Balldin J, Berggren U, Engel J, Lindstedt G, Sundkler A, Wålinder J: Alpha-2-adrenoceptor sensitivity in early alcohol withdrawal. Biol Psychiatry 1992;31:712-719.
38. Murad F: Drugs used for the treatment of angina: Organic nitrates, calcium-channel blockers, and β-adrenergic antagonists; in Gilman AG, Rall TW, Nies AS, Taylor P (eds): Goodman and Gilman's The Pharmacological basis of Therapeutics. New York, Pergamon Press, 1990, pp 764-783.
39. Linnoila M, Mefford I, Nutt D, Adinoff B: Alcohol withdrawal and noradrenergic function. Ann Intern Med 1987;107:875-889.
40. Hill KE, Ziegler DM, Konz KH, Haap M, Hunt RW, Burk RF: Nitroglycerin and isosorbide dinitrate stimulation of glutathione disulfide efflux from perfused rat liver. Biochem Pharmacol 1989;38:3807-3810.
41. Antonenkow VD, Panchenko LB: Effect of chronic ethanol treatment under partial catalase inhibition on the activity of enzymes related to peroxide metabolism in rat liver and heart. Int J Biochem 1988;20:823-828.
42. Ribiere C, Hininger I, Rouach H, Nordmann R: Effects of chronic ethanol administration of free radical defence in rat myocardium. Biochem Pharmacol 1992;44:1495-1500.